Merrimack Pharma Will Present Added Data Results in Phase 3 NAPOLI-q Study at ESMO
June 17, 2014 at 08:03 AM EDT
Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) today announced that results of the successful Phase 3 NAPOLI-1 study in metastatic ...